%3CLINGO-SUB%20id%3D%22lingo-sub-30490%22%20slang%3D%22en-US%22%3ED%C3%A9buter%20avec%20la%20surveillance%20bas%C3%A9e%20sur%20le%20risque%3C%2FLINGO-SUB%3E%3CLINGO-BODY%20id%3D%22lingo-body-30490%22%20slang%3D%22en-US%22%3E%3CP%3ENotre%20propre%20Richard%20Zink%20a%20beaucoup%20%C3%A9crit%20sur%20le%20%3CA%20href%3D%22http%3A%2F%2Fwww.jmp.com%2Fen_us%2Fsoftware%2Fjmp-clinical%2Frisk-based-monitoring.html%22%20rel%3D%22noopener%20noreferrer%22%20target%3D%22_blank%22%3E%20surveillance%20ax%C3%A9e%20sur%20les%20risques%20%3C%2FA%3E%20(RBM)%20capacit%C3%A9s%20dans%20%3CA%20href%3D%22http%3A%2F%2Fwww.jmp.com%2Fsoftware%2Fclinical%2F%22%20rel%3D%22noopener%20noreferrer%22%20target%3D%22_blank%22%3E%20JMP%20Clinical%20%3C%2FA%3E%20%2C%20%C3%A0%20la%20fois%20sur%20%3CA%20href%3D%22http%3A%2F%2Fblogs.sas.com%2Fcontent%2Fjmp%2Ftag%2Frisk-based-monitoring%2F%22%20rel%3D%22noopener%20noreferrer%22%20target%3D%22_blank%22%3E%20ce%20blog%20%3C%2FA%3E%20et%2C%20bien%20s%C3%BBr%2C%20dans%20%3CA%20href%3D%22http%3A%2F%2Fwww.sas.com%2Fjmpstore%2Fbooks%2Fproducts-solutions%2Fjmp%2Frisk-based-monitoring-and-fraud-detection-in-clinical-trials-using-jmp-and-sas-%2FprodBK_67263_en.html%22%20rel%3D%22noopener%20noreferrer%22%20target%3D%22_blank%22%3E%20son%20livre%20%3C%2FA%3E%20.%3C%2FP%3E%3CP%3E%3C%2FP%3E%3CP%3E%3CA%20href%3D%22http%3A%2F%2Fwww.jmp.com%2Fimages%2Fsoftware%2Fclinical%2Frbm%2Frisk-based-monitoring-process.png%22%20rel%3D%22noopener%20noreferrer%22%20target%3D%22_blank%22%3E%3CIMG%20src%3D%22http%3A%2F%2Fwww.jmp.com%2Fimages%2Fsoftware%2Fclinical%2Frbm%2Frisk-based-monitoring-process.png%22%20alt%3D%22Diagramme%20de%20surveillance%20bas%C3%A9%20sur%20les%20risques%22%20width%3D%22330%22%20height%3D%22225%22%20%2F%3E%3C%2FA%3E%3C%2FP%3E%3CP%20class%3D%22wp-caption-text%22%3E%3CSTRONG%3E%20Un%20processus%20de%20surveillance%20bas%C3%A9%20sur%20les%20risques%20alimente%20les%20donn%C3%A9es%20des%20sites%20d'%C3%A9tude%20dans%20un%20tableau%20de%20bord%2C%20qui%20alerte%20ensuite%20le%20sponsor%20des%20situations%20qui%20n%C3%A9cessitent%20une%20enqu%C3%AAte%20plus%20approfondie.%3C%2FSTRONG%3E%3C%2FP%3E%3CP%3E%3C%2FP%3E%3CP%3E%3C%2FP%3E%3CP%3EEn%20compl%C3%A9ment%20de%20la%20richesse%20des%20informations%20pratiques%20cr%C3%A9%C3%A9es%20par%20Richard%2C%20qui%20couvre%20principalement%20les%20m%C3%A9canismes%20de%20la%20GAR%20avec%20le%20logiciel%20JMP%2C%20nous%20avons%20d%C3%A9cid%C3%A9%20de%20publier%20un%20bref%20article%20sur%20%3CA%20href%3D%22http%3A%2F%2Fwww.jmp.com%2Fen_us%2Fsoftware%2Fjmp-clinical%2Frisk-based-monitoring.html%22%20rel%3D%22noopener%20noreferrer%22%20target%3D%22_blank%22%3E%20se%20lancer%20dans%20la%20surveillance%20ax%C3%A9e%20sur%20les%20risques%20%3C%2FA%3E%20.%3C%2FP%3E%3CP%3E%3C%2FP%3E%3CP%3EL'article%20couvre%20plusieurs%20aspects%20de%20la%20GAR%2C%20notamment%3A%3C%2FP%3E%3CP%3E%3CUL%3E%3C%2FUL%3E%3C%2FP%3E%3CP%3E%3CLI%3EUne%20d%C3%A9finition%20de%20base.%3C%2FLI%3E%3C%2FP%3E%3CP%3E%3CLI%3EPourquoi%20une%20approche%20bas%C3%A9e%20sur%20les%20risques%20est-elle%20meilleure%20(indice%3A%20c'est%20beaucoup%20moins%20cher).%3C%2FLI%3E%3C%2FP%3E%3CP%3E%3CLI%3ED%C3%A9tails%20sur%20le%20fonctionnement%20du%20processus%20de%20surveillance%20dans%20ce%20nouveau%20mod%C3%A8le.%3C%2FLI%3E%3C%2FP%3E%3CP%3E%3CLI%3EVue%20d'ensemble%20du%20tableau%20de%20bord%20des%20risques%2C%20%C3%A9l%C3%A9ment%20cl%C3%A9%20d'une%20plate-forme%20RBM.%3C%2FLI%3E%3C%2FP%3E%3CP%3E%3CLI%3EComment%20aborder%20la%20transition%20vers%20la%20gestion%20ax%C3%A9e%20sur%20les%20r%C3%A9sultats%20et%20faire%20face%20au%20changement%20organisationnel.%3C%2FLI%3E%3C%2FP%3E%3CP%3E%3C%2FP%3E%3CP%3EAu%20mieux%2C%20nous%20esp%C3%A9rons%20que%20l'article%20facilite%20certaines%20conversations%20au%20sein%20de%20votre%20organisation%20lors%20de%20la%20transition%20vers%20le%20nouveau%20monde%20de%20la%20surveillance%20des%20essais%20bas%C3%A9s%20sur%20les%20risques.%3C%2FP%3E%3CP%3E%3C%2FP%3E%3CP%3E%3CSTRONG%3E%3CA%20href%3D%22http%3A%2F%2Fwww.jmp.com%2Fen_us%2Fsoftware%2Fjmp-clinical%2Frisk-based-monitoring.html%22%20rel%3D%22noopener%20noreferrer%22%20target%3D%22_blank%22%3ELisez%20le%20guide%20pour%20d%C3%A9marrer%20avec%20la%20surveillance%20bas%C3%A9e%20sur%20les%20risques.%3C%2FA%3E%3C%2FSTRONG%3E%3C%2FP%3E%3C%2FLINGO-BODY%3E
Choose Language Hide Translation Bar
bencovington
Staff (Retired)
Getting started with risk-based monitoring

Our own Richard Zink has written extensively about the risk-based monitoring (RBM) capabilities in JMP Clinical, both on this blog and, of course, in his book.

Risk-based monitoring diagram

A risk-based monitoring process feeds data from study sites into a dashboard, which then alerts the sponsor to situations that need further investigation.

As a complement to the wealth of hands-on information that Richard has created, which primarily covers the mechanics of RBM with JMP software, we decided to publish a brief article on getting started with risk-based monitoring.

The article covers several aspects of RBM, including:

  • A basic definition.
  • Why a risk-based approach is better (hint: it's a lot cheaper).
  • Details about how the monitoring process might work in this new model.
  • An overview of the risk dashboard, a key piece of an RBM platform.
  • How to approach the transition to RBM and dealing with organizational change.
  • If nothing else, we hope the article facilitates some conversations in your organization as you transition to the new world of risk-based trial monitoring.

    Read the guide to getting started with risk-based monitoring.

    Article Labels

      There are no labels assigned to this post.